本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Jasper Therapeutics

0.5701
-0.0627-9.91%
盤後0.60000.0299+5.24%19:30 EDT
成交量:40.26萬
成交額:24.38萬
市值:1,896.98萬
市盈率:-0.61
高:0.6438
開:0.6400
低:0.5679
收:0.6328
52周最高:2.69
52周最低:0.3151
股本:3,327.46萬
流通股本:2,999.67萬
量比:1.74
換手率:1.34%
股息:- -
股息率:- -
每股收益(TTM):-0.9300
每股收益(LYR):-3.9545
淨資產收益率:-255.05%
總資產收益率:-113.41%
市淨率:13.43
市盈率(LYR):-0.14

資料載入中...

2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans